Previous studies have demonstrated that the presence of cardiomegaly on the routine chest roentgenogram
in patients with coronary artery disease (CAD) constitutes a high-risk prognostic indicator. This study was
designed to test the value of the measurement of the left ventricular end-diastolic diameter (LVEDD) on echocardiography,
a more precise measure of left ventricular size than is offered by the routine chest roentgenogram, as a
mortality risk indicator in patients with previous myocardial infarction. One hundred and twenty-three patients
observed at an average of 14 months post-myocardial infarction, with a mean follow-up of 44 months, were studied.
The normal mean ± 1 SD for LVEDD was 47.2 ± 4.3 mm. The upper normal limit of LVEDD was set at +2 SD
from the normal mean (56 mm). Fifty-two patients had increased LVEDD (> 56 mm) and the remaining 71 had
normal LVEDD (<56 mm). There were 28 cardiac deaths. Cumulative 5-year survival was 88% in patients with
normal LVEDD and 55% in those with increased LVEDD (p = 0.0002). Patient groups with normal (< 56 mm),
moderately increased (56-60) and markedly increased LVEDD (>60 mm) exhibited decreasing survival with
increasing LVEDD (p = 0.0002). Multivariate analysis demonstrated that the LVEDD adds significantly to the risk
stratification potency of left ventricular systolic function determined from the systolic time intervals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.